NASDAQ:SRTS

Sensus Healthcare - SRTS Stock Forecast, Price & News

$12.10

-0.56 (-4.42%)

(As of 10/5/2022 12:00 AM ET)

Add

Compare

Today's Range: $11.55
▼
$12.59
50-Day Range: $10.92
▼
$14.97
52-Week Range: $3.59
▼
$15.25

Volume: 435,633 shs
Average Volume: 377,356 shs
Market Capitalization: $200.38 million

P/E Ratio: 8.01
Dividend Yield: N/A
Price Target: $13.50

Sensus Healthcare MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 11.6% Upside
$13.50 Price Target
Short Interest: Healthy
3.78% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.02
Based on 3 Articles This Week
Insider Trading: Selling Shares
$1.13 M Sold Last Quarter
Proj. Earnings Growth: 23.38%
From $0.77 to $0.95 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.48 out of 5 stars

Medical Sector

266th out of 1,072 stocks

Surgical & Medical Instruments Industry

27th out of 103 stocks

2.5

Analyst's Opinion

Consensus Rating
Sensus Healthcare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $13.50, Sensus Healthcare has a forecasted upside of 11.6% from its current price of $12.10.
Amount of Analyst Coverage
Sensus Healthcare has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
3.78% of the float of Sensus Healthcare has been sold short.
Short Interest Ratio / Days to Cover
Sensus Healthcare has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Sensus Healthcare has recently increased by 27.10%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Sensus Healthcare does not currently pay a dividend.
Dividend Growth
Sensus Healthcare does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SRTS.

3.9

News and Social Media Coverage

News Sentiment
Sensus Healthcare has a news sentiment score of 1.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Sensus Healthcare this week, compared to 1 article on an average week.
Search Interest
23 people have searched for SRTS on MarketBeat in the last 30 days. This is an increase of 109% compared to the previous 30 days.
MarketBeat Follows
6 people have added Sensus Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Sensus Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,126,852.00 in company stock.
Percentage Held by Insiders
16.36% of the stock of Sensus Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 31.52% of the stock of Sensus Healthcare is held by institutions.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Sensus Healthcare are expected to grow by 23.38% in the coming year, from $0.77 to $0.95 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Sensus Healthcare is 8.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 125.03.
Price to Earnings Ratio vs. Sector
The P/E ratio of Sensus Healthcare is 8.01, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 125.76.
Price to Book Value per Share Ratio
Sensus Healthcare has a P/B Ratio of 7.71. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Sensus Healthcare (NASDAQ:SRTS) Stock

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Receive SRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SRTS Stock News Headlines

October 4, 2022 | finance.yahoo.com

The Zacks Analyst Blog Highlights TransMedics, PROCEPT BioRobotics and Sensus Healthcare

October 3, 2022 | finance.yahoo.com

3 Resilient Medical Stocks to Watch as Rate Hikes Continue

October 6, 2022 | Legacy Research (Ad)

Reclusive trader scores 20 years of winning trades. Learn how.

He had 20 straight years of winning trades without a single losing year… He had 20 straight years of winning trades without a single losing year… And now, he is coming forward to share a brand-new forecast.

September 27, 2022 | finance.yahoo.com

EDAP TMS S.A. (EDAP) Moves 7.3% Higher: Will This Strength Last?

September 24, 2022 | finance.yahoo.com

Sensus Healthcare, Inc.'s (NASDAQ:SRTS) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

September 17, 2022 | seekingalpha.com

SRTS Sensus Healthcare, Inc.

September 16, 2022 | theglobeandmail.com

Take Advantage of the Dip: 3 Top Stocks To Consider

September 15, 2022 | nasdaq.com

Sensus Healthcare (NASDAQ:SRTS) shareholder returns have been massive, earning 316% in 1 year

October 6, 2022 | Legacy Research (Ad)

Reclusive trader scores 20 years of winning trades. Learn how.

September 9, 2022 | finance.yahoo.com

Sensus Healthcare to Present at the H.C. Wainwright 24th Annual Global Investment Conference

September 7, 2022 | finance.yahoo.com

Sensus Healthcare Adds Dr. Mohammad K. Khan to Medical Advisory Board

August 26, 2022 | finance.yahoo.com

A Look At The Fair Value Of Sensus Healthcare, Inc. (NASDAQ:SRTS)

August 12, 2022 | benzinga.com

Chief Executive Officer Of Sensus Healthcare Makes $2.24M Sale

August 10, 2022 | nasdaq.com

Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger

August 10, 2022 | finance.yahoo.com

Is Sensus Healthcare, Inc. (NASDAQ:SRTS) Popular Amongst Insiders?

August 8, 2022 | seekingalpha.com

Sensus Healthcare: Best In The Industry With Significant Growth Prospects

August 7, 2022 | seekingalpha.com

Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q2 2022 Results - Earnings Call Transcript

August 4, 2022 | finance.yahoo.com

Sensus Healthcare, Inc. (SRTS) Q2 Earnings and Revenues Top Estimates

August 4, 2022 | finance.yahoo.com

Sensus Healthcare Second Quarter 2022 Financial Results Feature Revenue Growth of 124%

July 27, 2022 | finance.yahoo.com

Sensus Healthcare Takes Order for 10 TransDermal Infusion Systems™ Supporting Hair Enhancement Centers Expansion Along with U.SK Under Skin’s Hair-Health Serum

July 26, 2022 | finance.yahoo.com

Sensus Healthcare to Host Second Quarter 2022 Financial Results and Business Update Conference Call on August 4, 2022

July 21, 2022 | finance.yahoo.com

Sensus Healthcare, Inc. (SRTS) Is a Great Choice for "Trend" Investors, Here's Why

July 20, 2022 | nz.finance.yahoo.com

Colorado State University College of Veterinary Medicine and Biomedical Sciences Acquires Second SRT System from Sensus Healthcare

July 18, 2022 | finance.yahoo.com

Sensus Healthcare, Inc. (SRTS) Soars 8.7%: Is Further Upside Left in the Stock?

July 1, 2022 | finance.yahoo.com

Is the Options Market Predicting a Spike in Sensus Healthcare (SRTS) Stock?

June 28, 2022 | finance.yahoo.com

HCA Healthcare (HCA) Boosts Cancer Portfolio With McKesson JV

June 4, 2022 | finance.yahoo.com

Those who invested in Sensus Healthcare (NASDAQ:SRTS) a year ago are up 152%

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive SRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SRTS Company Calendar

Last Earnings: 8/04/2022
Today: 10/06/2022
Next Earnings (Estimated): 11/03/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:SRTS
CUSIP: N/A
CIK: 1494891
Web: www.sensushealthcare.com
Phone: (561) 922-5808
Fax: 561-948-2071
Employees: 37
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $13.50
High Stock Price Forecast: $14.00
Low Stock Price Forecast: $13.00
Forecasted Upside/Downside: +11.6%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.51
Trailing P/E Ratio: 8.01
Forward P/E Ratio: 15.71
P/E Growth: N/A
Net Income: $4.12 million
Net Margins: 61.26%
Pretax Margin: 65.46%
Return on Equity: 41.49%
Return on Assets: 33.06%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 5.01
Quick Ratio: 4.84

Sales & Book Value

Annual Sales: $27.04 million
Price / Sales: 7.41
Cash Flow: $0.27 per share
Price / Cash Flow: 44.46
Book Value: $1.57 per share
Price / Book: 7.71

Miscellaneous

Outstanding Shares: 16,560,000
Free Float: 13,847,000
Market Cap: $200.38 million
Optionable: Not Optionable
Beta: 0.74

Key Executives

Mr. Joseph C. Sardano (Age 69)
Co-Founder, Chairman & CEO
Comp: $630.45k

Mr. Michael J. Sardano (Age 33)
Pres & Gen. Counsel
Comp: $273.37k

Mr. Javier Rampolla (Age 49)
Chief Financial Officer

Mr. Nicolas Soro (Age 37)
Chief Operating Officer

Mr. Yonatan Vainer (Age 35)
Chief Technology Officer

Mr. Benson Suen
VP of International Sales

Dr. Mark S. Nestor
Medical Director & Member of Medical Advisory Board

Dr. Clay Jefferies Cockerell (Age 65)
Clinical Director & Member of Medical Advisory Board

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SRTS Stock - Frequently Asked Questions

Should I buy or sell Sensus Healthcare stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SRTS shares.
View SRTS analyst ratings or view top-rated stocks.
What is Sensus Healthcare's stock price forecast for 2022?: 2 analysts have issued 12 month price targets for Sensus Healthcare's shares. Their SRTS share price forecasts range from $13.00 to $14.00. On average, they expect the company's stock price to reach $13.50 in the next twelve months. This suggests a possible upside of 11.6% from the stock's current price.
View analysts price targets for SRTS or view top-rated stocks among Wall Street analysts.
How have SRTS shares performed in 2022?: Sensus Healthcare's stock was trading at $7.22 at the beginning of 2022. Since then, SRTS stock has increased by 67.6% and is now trading at $12.10.
View the best growth stocks for 2022 here.
When is Sensus Healthcare's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our SRTS earnings forecast.
How were Sensus Healthcare's earnings last quarter?: Sensus Healthcare, Inc. (NASDAQ:SRTS) released its earnings results on Thursday, August, 4th. The company reported $0.21 EPS for the quarter, beating analysts' consensus estimates of $0.18 by $0.03. The business earned $12.08 million during the quarter, compared to the consensus estimate of $10.28 million. Sensus Healthcare had a trailing twelve-month return on equity of 41.49% and a net margin of 61.26%.

What other stocks do shareholders of Sensus Healthcare own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Sorrento Therapeutics (SRNE), Corbus Pharmaceuticals (CRBP), Nabriva Therapeutics (NBRV), Sangamo Therapeutics (SGMO), Viking Therapeutics (VKTX), Vaxart (VXRT), Amarin (AMRN), Palatin Technologies (PTN) and QUALCOMM (QCOM).
When did Sensus Healthcare IPO?: (SRTS) raised $20 million in an initial public offering (IPO) on Wednesday, March 30th 2016. The company issued 1,800,000 shares at a price of $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.
What is Sensus Healthcare's stock symbol?: Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS."
How do I buy shares of Sensus Healthcare?: Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Sensus Healthcare's stock price today?: One share of SRTS stock can currently be purchased for approximately $12.10.
How much money does Sensus Healthcare make?: Sensus Healthcare (NASDAQ:SRTS) has a market capitalization of $200.33 million and generates $27.04 million in revenue each year. The company earns $4.12 million in net income (profit) each year or $1.51 on an earnings per share basis.
How can I contact Sensus Healthcare?: Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The official website for the company is www.sensushealthcare.com. The company can be reached via phone at (561) 922-5808, via email at kgolodetz@lhai.com, or via fax at 561-948-2071.

This page (NASDAQ:SRTS) was last updated on 10/6/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Sensus Healthcare - SRTS Stock Forecast, Price & News

Sensus Healthcare MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows